Chongqing Pharscin Pharmaceutical Co., Ltd.
SZSE:002907.SZ
16.07 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||||
| Current Assets: | |||||||||||
| Cash & Cash Equivalents
| 437.565 | 503.529 | 429.968 | 481.405 | 286.796 | 243.316 | 67.301 | 85.21 | 54.656 | 55.922 | 30.911 |
| Short Term Investments
| 0 | -18.97 | 80.608 | 50.068 | 193.245 | 0 | 176 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 437.565 | 503.529 | 510.575 | 531.473 | 480.042 | 243.316 | 67.301 | 85.21 | 54.656 | 55.922 | 30.911 |
| Net Receivables
| 249.75 | 315.032 | 238.502 | 225.988 | 297.897 | 258.791 | 248.187 | 262.619 | 193.368 | 230.175 | 164.629 |
| Inventory
| 151.677 | 114.756 | 127.437 | 118.567 | 86.395 | 56.362 | 51.023 | 42.586 | 40.273 | 36.605 | 27.715 |
| Other Current Assets
| 55.647 | 37.61 | 17.583 | 12.983 | 7.167 | 20.523 | 194.928 | 6.249 | 22.536 | 17.338 | 164.813 |
| Total Current Assets
| 894.639 | 956.949 | 894.098 | 889.011 | 871.501 | 578.992 | 561.438 | 396.664 | 310.834 | 340.039 | 223.439 |
| Non-Current Assets: | |||||||||||
| Property, Plant & Equipment, Net
| 593.415 | 621.942 | 654.212 | 673.615 | 629.046 | 319.506 | 233.123 | 163.334 | 158.368 | 157.136 | 155.962 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 158.941 | 115.22 | 99.72 | 73.655 | 77.634 | 76.226 | 75.979 | 77.925 | 62.394 | 29.574 | 30.182 |
| Goodwill and Intangible Assets
| 158.941 | 115.22 | 99.72 | 73.655 | 77.634 | 76.226 | 75.979 | 77.925 | 62.394 | 29.574 | 30.182 |
| Long Term Investments
| 98.386 | 103.445 | -23.557 | -13.146 | -178.245 | 11.635 | 11.574 | 12.259 | 5.624 | 0 | 0 |
| Tax Assets
| 15.688 | 18.661 | 16.956 | 18.59 | 12.219 | 3.904 | 2.758 | 1.575 | 1.132 | 3.326 | 4.072 |
| Other Non-Current Assets
| 90.385 | 50.45 | 130.054 | 79.688 | 225.315 | 103.368 | 0.275 | 0.566 | 0.943 | 7.32 | 1.698 |
| Total Non-Current Assets
| 956.815 | 909.717 | 877.386 | 832.402 | 765.969 | 514.638 | 323.71 | 255.659 | 228.46 | 197.355 | 191.914 |
| Total Assets
| 1,851.454 | 1,866.667 | 1,771.484 | 1,721.413 | 1,637.47 | 1,093.63 | 885.148 | 652.323 | 539.294 | 537.395 | 415.353 |
| Liabilities & Equity: | |||||||||||
| Current Liabilities: | |||||||||||
| Account Payables
| 55.233 | 48.043 | 76.103 | 92.045 | 144.09 | 60.286 | 36.026 | 61.688 | 74.913 | 43.489 | 35.455 |
| Short Term Debt
| 0 | 0 | 0 | 12.008 | 0 | 44 | 17 | 45 | 43 | 93.9 | 79.6 |
| Tax Payables
| 6.914 | 18.882 | 1.91 | 8.209 | 17.545 | 17.717 | 11.524 | 9.833 | 8.293 | 19.375 | 11.588 |
| Deferred Revenue
| 5.691 | 6.725 | 129.38 | 147.189 | 0.832 | 17.717 | 102.841 | 77.557 | 52.61 | 92.974 | 52.252 |
| Other Current Liabilities
| 120.839 | 137.669 | -0.422 | -3.556 | 140.647 | 109.256 | 93.452 | -3.17 | -5.231 | 73.599 | 47.744 |
| Total Current Liabilities
| 188.677 | 211.32 | 206.97 | 255.805 | 303.114 | 248.976 | 158.001 | 190.907 | 173.585 | 237.624 | 174.387 |
| Non-Current Liabilities: | |||||||||||
| Long Term Debt
| 0.14 | 0.058 | 250.993 | 235.557 | 220.291 | 4.7 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 43.034 | 43.595 | 46.328 | 46.983 | 41.39 | 11.04 | 7.2 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 1.681 | 1.305 | 1.272 | 1.452 | 1.873 | -4.7 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0 | 0 | 46.328 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Non-Current Liabilities
| 44.856 | 44.957 | 298.593 | 283.787 | 263.555 | 15.74 | 7.2 | 0 | 0 | 0 | 0 |
| Total Liabilities
| 233.533 | 256.277 | 505.564 | 539.592 | 566.669 | 264.716 | 165.201 | 190.907 | 173.585 | 237.624 | 174.387 |
| Equity: | |||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 417.596 | 417.596 | 401.691 | 401.701 | 401.547 | 400.06 | 400.06 | 360 | 300 | 80 | 80 |
| Retained Earnings
| 648.691 | 649.979 | 580.968 | 508.97 | 418.955 | 279.956 | 184.614 | 83.614 | 37.559 | 193.465 | 140.59 |
| Accumulated Other Comprehensive Income/Loss
| 0 | 92.716 | 71.811 | 63.606 | 129.799 | 42.048 | 28.423 | 17.802 | 28.15 | 0 | 0 |
| Other Total Stockholders Equity
| 551.633 | 542.927 | 283.262 | 207.544 | 168.002 | 148.898 | 135.272 | 0.367 | 20.367 | 18.612 | 12.732 |
| Total Shareholders Equity
| 1,617.921 | 1,610.39 | 1,265.92 | 1,181.822 | 1,070.8 | 828.914 | 719.946 | 461.417 | 365.709 | 292.077 | 233.322 |
| Total Equity
| 1,617.921 | 1,610.39 | 1,265.92 | 1,181.822 | 1,070.8 | 828.914 | 719.946 | 461.417 | 365.709 | 299.771 | 240.965 |
| Total Liabilities & Shareholders Equity
| 1,851.454 | 1,866.667 | 1,771.484 | 1,721.413 | 1,637.47 | 1,093.63 | 885.148 | 652.323 | 539.294 | 537.395 | 415.353 |